Medicure Inc. MCUJF
2.82 USD -0.10 (-3.42%)
Nov 5, 2026, 2:17 PM EST
2.82 Day range 2.84
0.67 52-week range 3.45
- YTD
- +252.50%
- 1 year
- +213.33%
- Market cap
- 31.60M
- EPS (ttm)
- -0.51
- YTD return
- +252.50%
- 1-year return
- +213.33%
- Volume
- 1.70K
- Avg volume
- 13.25K
- Open
- 2.82
- Previous close
- 2.92
- Day's range
- 2.82 – 2.84
- 52-week range
- 0.67 – 3.45
5D -0.33 (-10.48%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 25, 2024 | Sep 1, 2024 | 0.00 | 0.05 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.09 | — | — |
| May 28, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Apr 8, 2024 | Dec 1, 2023 | 0.00 | -0.10 | — | — |
| Nov 21, 2023 | Sep 1, 2023 | 0.00 | 0.01 | — | — |
| Jul 28, 2023 | Jun 1, 2023 | 0.00 | 0.01 | — | — |
News
Medicure (OTCMKTS:MCUJF) Share Price Breaks Above 50-Day Moving Average – What’s Next? 
Medicure (OTCMKTS:MCUJF) Shares Break Above 50-Day Moving Average – Time to Sell? 
Medicure Announces Grant of Stock Options 
Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial 
Medicure (OTCMKTS:MCUJF) Shares Cross Above 50-Day Moving Average – Should You Sell? 
Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress 
Medicure Inc. (MPH:CA) Q2 2026 Earnings Call Prepared Remarks Transcript 
Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call 
Comparing Medicure (OTCMKTS:MCUJF) & Takeda Pharmaceutical (NYSE:TAK) 
Medicure Announces CFO Change
Your note
Sign in to keep a note on MCUJF — it syncs with the Stock Master app.